Results

Total Results: 222 records

Showing results for "sedation".

21. Antipsychotics-Children-Surveillance-150120 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
    October 01, 2014 - One review (Ching & Pringsheim, 2012) found increased weight gain and higher risk ratios for sedation … Notable side effects must be considered, however, such as weight gain, sedation, drooling, and tremor … The most common AEs were sedation (26.5%), somnolence (23.5%), headache (22.2%), and insomnia (13.6% … Eight patients (20.0%) experienced moderate to severe sedation and eight (20.0%) experienced increased … For nearly all outcomes ratios for sedation and increased risk for weight regard to new evidence and

22. AHRQ Slide Template
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
    March 01, 2022 - Primary: efficacy outcomes (i.e., pain, overall function, adverse effects (e.g., dizziness, nausea, sedation … Size (N Studies) [SOE]a Dizziness Effect Size (N Studies) [SOE]a Nausea Effect Size (N Studies) [SOE]a Sedation … Cannabis products associated with increased risk of adverse events (dizziness, sedation, nausea); studies

23. Fraenkel (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/fraenkel.pdf
    May 29, 2025 - http://www.effectivehealthcare.ahrq.gov/index.cfm) � • Sedation

24. CER 220 Evidence Summary: Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-analgesics-acute-pain-summary.pdf
    September 01, 2019 - events, such as vomiting and subsequent airway obstruction, respiratory depression, hypotension, and sedation … at 15 min. dInsufficient for drowsiness, changes in RAAS, reduced GCS, sleepiness/tired, confusion, sedation … , difficulty concentrating. eFor dizziness, sedation. fInconclusive for mild sedation. gFor dizziness

25. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
    January 01, 2022 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

26. Migraine-Emergency Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
    November 01, 2012 - acute migraine Intervention Generic Name Trade Name(s) Mode of Administration Agents for Procedural Sedation … The results are presented by adverse effect categories (e.g., sedation, dizziness, vomiting). … Sedation/Somnolence Twenty-five studies reported on the development of sedation/somnolence, including … The risk of developing sedation/ somnolence as a result of taking a placebo was 5 percent (95% CI, 2 … The risk of experiencing sedation following administration of metoclopramide and prochlorperazine was

27. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
    April 01, 2020 - Duloxetine resulted in a large, dose- dependent, increase in sedation (SOE: Moderate to Low). … Additionally, pregabalin resulted in large increases in risk of peripheral edema and sedation (SOE: … Duloxetine also resulted in increased sedation, but lower doses did reduce the risk. … and gabapentin resulted in moderate to large increases in blurred vision, dizziness, weight gain, sedation … Additionally, pregabalin resulted in large increases in risk of peripheral edema and sedation.

28. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
    July 18, 2011 - Addressing sedation as an adverse event. … Sedation/somnolence b. Dizziness c. Restless legs/akathisia d. Anxiety e. Vomiting f. … Sedation/somnolence 2. Dizziness 3. Restless legs/akathisia 4. Anxiety 5. Vomiting 6. … in the ED, Visual Analog Scale score at discharge, and relapse after 48 hours) and safety (e.g., sedation … interventions for acute migraine Generic name Trade name(s) Mode of administration Agents for procedural sedation

29. Tinnitus Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
    August 01, 2013 - characteristics, and symptoms Comparative e�ectiveness of treatment interventions Worsening of tinnitus Sedation … subjective loudness, quality of life, tinnitus severity, adverse effects (worsening of tinnitus, sedation … subjective loudness, quality of life, return to “normal” work, adverse effects (worsening of tinnitus, sedation … The findings for sedation were inconsistent and imprecise, as estimates of affected patients were poorly … characterized; the SOE for sedation was insufficient in patients with tinnitus. 7 Table B.

30. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
    January 01, 2018 - FGAs are mainly associated with dry mouth, sedation, and extrapyramidal symptoms, which are movement … cause adverse effects including weight gain, high triglyceride levels, extrapyramidal symptoms, sedation … There may be little or no difference between classes for sedation. … • Sedation. … There may be little or no difference between olanzapine and risperidone for risk of sedation.

31. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
    December 23, 2015 - Untitled Source: www.effectivehealthcare.ahrq.gov Published online: December 23, 2015 Evidence-based Practice Center Systematic Review Protocol Project Title: Suicide Prevention I. Background and Objectives for the Systematic Review Despite advances in the diagnosis and treatment of major mental disord…

32. Engaging-Caregivers-Appendix-B (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
    May 29, 2025 - anticipated to be in the ICU for more than 48 hours; 2) Patients who had had any procedure(s) that required sedation … positive on the Confusion Assessment Method in the ICU tool; (4) Patients who had a Richmond Agitation-Sedation

33. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
    January 01, 2010 - Effective Health Care Topic Number(s): 0239 Document Completion Date: 8-13-10 1 Results of Topic Selection Process & Next Steps  Treatment of restless legs syndrome will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, comparato…

34. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … high THC to CBD) may be associated with moderate improvement in pain severity and increased risk of sedation … no effect on overall function/disability (SOE: low; 2 RCTs) Harms: moderate increased risk of sedation … Combined THC/CBD may also be associated with a moderate to large increased risk of dizziness, sedation … Sedation for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup)

35. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
    April 15, 2021 - In discussing the potential for adverse effects with brexanolone, sedation and loss of consciousness

36. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

37. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

38. Restless-Legs Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - Mirapex ® Yes Ritigotine Neupro ® Sedative- hypnotics Clonazepam Rivotril ® Tolerance; sedation … Gabapentin Neurontin ® Pregabalin Lyrica ® Opioids Hydrocodone -Vicodin ® -Lortab ® Sedation

39. Anesthesia | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/anesthesia

40. Autism-Update Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
    September 01, 2014 - .  Harms � Aripiprazole and risperidone are associated with significant weight gain, sedation,